Intrinsic value of Misonix - MSON

Previous Close

$15.07

  Intrinsic Value

$0.68

stock screener

  Rating & Target

str. sell

-96%

Previous close

$15.07

 
Intrinsic value

$0.68

 
Up/down potential

-96%

 
Rating

str. sell

We calculate the intrinsic value of MSON stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.1

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  60.00
  54.50
  49.55
  45.10
  41.09
  37.48
  34.23
  31.31
  28.68
  26.31
  24.18
  22.26
  20.53
  18.98
  17.58
  16.32
  15.19
  14.17
  13.26
  12.43
  11.69
  11.02
  10.42
  9.87
  9.39
  8.95
  8.55
  8.20
  7.88
  7.59
Revenue, $m
  44
  67
  101
  146
  206
  284
  381
  500
  643
  813
  1,009
  1,234
  1,487
  1,770
  2,081
  2,420
  2,788
  3,183
  3,605
  4,053
  4,527
  5,026
  5,549
  6,097
  6,669
  7,266
  7,888
  8,534
  9,207
  9,905
Variable operating expenses, $m
  55
  84
  126
  183
  258
  355
  476
  625
  804
  1,015
  1,261
  1,541
  1,858
  2,210
  2,599
  3,023
  3,482
  3,976
  4,503
  5,063
  5,654
  6,277
  6,931
  7,616
  8,330
  9,076
  9,852
  10,660
  11,500
  12,373
Fixed operating expenses, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  55
  84
  126
  183
  258
  355
  476
  625
  804
  1,015
  1,261
  1,541
  1,858
  2,210
  2,599
  3,023
  3,482
  3,976
  4,503
  5,063
  5,654
  6,277
  6,931
  7,616
  8,330
  9,076
  9,852
  10,660
  11,500
  12,373
Operating income, $m
  -11
  -17
  -25
  -37
  -52
  -71
  -95
  -125
  -161
  -203
  -251
  -307
  -370
  -441
  -518
  -603
  -694
  -793
  -898
  -1,010
  -1,128
  -1,252
  -1,382
  -1,519
  -1,661
  -1,810
  -1,965
  -2,126
  -2,293
  -2,467
EBITDA, $m
  -10
  -15
  -22
  -32
  -45
  -62
  -83
  -109
  -141
  -178
  -221
  -270
  -325
  -387
  -455
  -529
  -610
  -696
  -788
  -886
  -990
  -1,099
  -1,214
  -1,334
  -1,459
  -1,589
  -1,725
  -1,867
  -2,014
  -2,166
Interest expense (income), $m
  0
  0
  0
  0
  1
  1
  2
  3
  4
  5
  6
  8
  10
  13
  15
  18
  22
  25
  29
  33
  38
  42
  47
  52
  58
  64
  70
  76
  82
  89
  96
Earnings before tax, $m
  -11
  -17
  -26
  -37
  -53
  -73
  -98
  -129
  -166
  -209
  -260
  -318
  -383
  -456
  -537
  -624
  -720
  -822
  -931
  -1,047
  -1,170
  -1,299
  -1,435
  -1,577
  -1,725
  -1,880
  -2,041
  -2,208
  -2,382
  -2,564
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  -11
  -17
  -26
  -37
  -53
  -73
  -98
  -129
  -166
  -209
  -260
  -318
  -383
  -456
  -537
  -624
  -720
  -822
  -931
  -1,047
  -1,170
  -1,299
  -1,435
  -1,577
  -1,725
  -1,880
  -2,041
  -2,208
  -2,382
  -2,564

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  44
  67
  101
  146
  207
  284
  381
  501
  644
  814
  1,010
  1,235
  1,489
  1,771
  2,083
  2,423
  2,791
  3,186
  3,609
  4,057
  4,531
  5,031
  5,555
  6,103
  6,676
  7,273
  7,895
  8,543
  9,216
  9,915
Adjusted assets (=assets-cash), $m
  44
  67
  101
  146
  207
  284
  381
  501
  644
  814
  1,010
  1,235
  1,489
  1,771
  2,083
  2,423
  2,791
  3,186
  3,609
  4,057
  4,531
  5,031
  5,555
  6,103
  6,676
  7,273
  7,895
  8,543
  9,216
  9,915
Revenue / Adjusted assets
  1.000
  1.000
  1.000
  1.000
  0.995
  1.000
  1.000
  0.998
  0.998
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
  0.999
Average production assets, $m
  7
  11
  17
  24
  34
  47
  62
  82
  106
  133
  166
  202
  244
  290
  341
  397
  457
  522
  591
  665
  742
  824
  910
  1,000
  1,094
  1,192
  1,294
  1,400
  1,510
  1,624
Working capital, $m
  9
  15
  22
  32
  45
  61
  82
  108
  139
  176
  218
  267
  321
  382
  449
  523
  602
  688
  779
  875
  978
  1,086
  1,199
  1,317
  1,441
  1,569
  1,704
  1,843
  1,989
  2,140
Total debt, $m
  3
  8
  14
  23
  35
  50
  69
  92
  120
  153
  191
  234
  284
  338
  399
  465
  536
  613
  695
  782
  874
  971
  1,072
  1,179
  1,290
  1,406
  1,526
  1,652
  1,783
  1,918
Total liabilities, $m
  8
  13
  20
  28
  40
  55
  74
  97
  125
  158
  196
  240
  289
  344
  404
  470
  541
  618
  700
  787
  879
  976
  1,078
  1,184
  1,295
  1,411
  1,532
  1,657
  1,788
  1,924
Total equity, $m
  35
  54
  81
  118
  167
  229
  307
  403
  519
  656
  814
  995
  1,200
  1,428
  1,679
  1,953
  2,249
  2,568
  2,909
  3,270
  3,652
  4,055
  4,477
  4,919
  5,381
  5,862
  6,364
  6,885
  7,428
  7,992
Total liabilities and equity, $m
  43
  67
  101
  146
  207
  284
  381
  500
  644
  814
  1,010
  1,235
  1,489
  1,772
  2,083
  2,423
  2,790
  3,186
  3,609
  4,057
  4,531
  5,031
  5,555
  6,103
  6,676
  7,273
  7,896
  8,542
  9,216
  9,916
Debt-to-equity ratio
  0.090
  0.140
  0.180
  0.200
  0.210
  0.220
  0.220
  0.230
  0.230
  0.230
  0.230
  0.240
  0.240
  0.240
  0.240
  0.240
  0.240
  0.240
  0.240
  0.240
  0.240
  0.240
  0.240
  0.240
  0.240
  0.240
  0.240
  0.240
  0.240
  0.240
Adjusted equity ratio
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806
  0.806

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -11
  -17
  -26
  -37
  -53
  -73
  -98
  -129
  -166
  -209
  -260
  -318
  -383
  -456
  -537
  -624
  -720
  -822
  -931
  -1,047
  -1,170
  -1,299
  -1,435
  -1,577
  -1,725
  -1,880
  -2,041
  -2,208
  -2,382
  -2,564
Depreciation, amort., depletion, $m
  2
  2
  3
  5
  7
  9
  12
  15
  20
  25
  31
  37
  45
  54
  63
  74
  85
  97
  109
  123
  137
  153
  169
  185
  203
  221
  240
  259
  280
  301
Funds from operations, $m
  -10
  -15
  -22
  -33
  -46
  -64
  -86
  -113
  -146
  -184
  -229
  -280
  -338
  -402
  -473
  -551
  -635
  -725
  -822
  -924
  -1,032
  -1,146
  -1,266
  -1,391
  -1,522
  -1,659
  -1,801
  -1,949
  -2,103
  -2,263
Change in working capital, $m
  4
  5
  7
  10
  13
  17
  21
  26
  31
  37
  42
  49
  55
  61
  67
  73
  79
  85
  91
  97
  102
  108
  113
  118
  124
  129
  134
  140
  145
  151
Cash from operations, $m
  -13
  -20
  -30
  -43
  -59
  -81
  -107
  -139
  -177
  -221
  -271
  -329
  -393
  -463
  -541
  -624
  -714
  -810
  -913
  -1,021
  -1,135
  -1,254
  -1,379
  -1,510
  -1,646
  -1,788
  -1,935
  -2,089
  -2,248
  -2,414
Maintenance CAPEX, $m
  -1
  -1
  -2
  -3
  -4
  -6
  -9
  -12
  -15
  -20
  -25
  -31
  -37
  -45
  -54
  -63
  -74
  -85
  -97
  -109
  -123
  -137
  -153
  -169
  -185
  -203
  -221
  -240
  -259
  -280
New CAPEX, $m
  -3
  -4
  -5
  -7
  -10
  -13
  -16
  -20
  -24
  -28
  -32
  -37
  -42
  -46
  -51
  -56
  -60
  -65
  -69
  -73
  -78
  -82
  -86
  -90
  -94
  -98
  -102
  -106
  -110
  -115
Cash from investing activities, $m
  -4
  -5
  -7
  -10
  -14
  -19
  -25
  -32
  -39
  -48
  -57
  -68
  -79
  -91
  -105
  -119
  -134
  -150
  -166
  -182
  -201
  -219
  -239
  -259
  -279
  -301
  -323
  -346
  -369
  -395
Free cash flow, $m
  -17
  -25
  -37
  -53
  -74
  -100
  -132
  -170
  -215
  -268
  -328
  -396
  -472
  -555
  -645
  -743
  -848
  -960
  -1,079
  -1,204
  -1,335
  -1,473
  -1,618
  -1,768
  -1,925
  -2,088
  -2,258
  -2,434
  -2,618
  -2,808
Issuance/(repayment) of debt, $m
  3
  5
  6
  9
  12
  15
  19
  23
  28
  33
  38
  44
  49
  55
  60
  66
  71
  77
  82
  87
  92
  97
  102
  106
  111
  116
  121
  126
  131
  136
Issuance/(repurchase) of shares, $m
  25
  36
  53
  74
  101
  135
  176
  225
  281
  346
  418
  499
  588
  684
  788
  898
  1,016
  1,141
  1,271
  1,409
  1,552
  1,701
  1,857
  2,019
  2,187
  2,361
  2,542
  2,730
  2,925
  3,127
Cash from financing (excl. dividends), $m  
  28
  41
  59
  83
  113
  150
  195
  248
  309
  379
  456
  543
  637
  739
  848
  964
  1,087
  1,218
  1,353
  1,496
  1,644
  1,798
  1,959
  2,125
  2,298
  2,477
  2,663
  2,856
  3,056
  3,263
Total cash flow (excl. dividends), $m
  12
  16
  22
  30
  39
  51
  64
  78
  94
  111
  128
  146
  165
  184
  203
  221
  239
  257
  275
  292
  309
  325
  341
  357
  373
  389
  405
  421
  438
  455
Retained Cash Flow (-), $m
  -25
  -36
  -53
  -74
  -101
  -135
  -176
  -225
  -281
  -346
  -418
  -499
  -588
  -684
  -788
  -898
  -1,016
  -1,141
  -1,271
  -1,409
  -1,552
  -1,701
  -1,857
  -2,019
  -2,187
  -2,361
  -2,542
  -2,730
  -2,925
  -3,127
Prev. year cash balance distribution, $m
  6
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  -7
  -21
  -31
  -44
  -62
  -85
  -113
  -147
  -188
  -235
  -290
  -353
  -422
  -500
  -585
  -677
  -777
  -883
  -997
  -1,117
  -1,243
  -1,377
  -1,516
  -1,662
  -1,814
  -1,972
  -2,137
  -2,309
  -2,487
  -2,672
Discount rate, %
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
  -7
  -19
  -27
  -36
  -48
  -61
  -76
  -92
  -108
  -123
  -138
  -150
  -161
  -168
  -172
  -172
  -169
  -163
  -153
  -142
  -129
  -114
  -99
  -85
  -71
  -58
  -46
  -36
  -27
  -20
Current shareholders' claim on cash, %
  81.7
  67.8
  56.8
  48.1
  41.1
  35.4
  30.7
  26.8
  23.6
  20.8
  18.5
  16.5
  14.7
  13.2
  11.9
  10.8
  9.8
  8.9
  8.1
  7.4
  6.7
  6.2
  5.7
  5.2
  4.8
  4.4
  4.0
  3.7
  3.4
  3.2

Misonix, Inc. designs, manufactures, develops and markets minimally invasive therapeutic ultrasonic medical devices. The Company's products include BoneScalpel surgical system (BoneScalpel), SonaStar Surgical Aspirator (SonaStar), and SonicOne Wound Cleansing and Debridement System (SonicOne). These devices primarily serve the neurosurgery, orthopedic surgery, plastic surgery, wounds, burn and maxillo-facial clinical specialties. The BoneScalpel is an ultrasonic cutting system that makes cuts with minimal necrosis, minimal burn artifact, minimal inflammation and minimal bone loss. The SonaStar system provides precise aspiration following the ultrasonic ablation of hard or soft tissue. The SonicOne Ultrasonic Cleansing and Debridement System is a tissue specific approach for the removal of devitalized or necrotic tissue and fibrin deposits while sparing viable, surrounding cellular structures.

FINANCIAL RATIOS  of  Misonix (MSON)

Valuation Ratios
P/E Ratio -70.5
Price to Sales 5.2
Price to Book 5
Price to Tangible Book
Price to Cash Flow -141.1
Price to Free Cash Flow -141.1
Growth Rates
Sales Growth Rate 17.4%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate NaN%
Cap. Spend. - 3 Yr. Gr. Rate NaN%
Financial Strength
Quick Ratio NaN
Current Ratio 0
LT Debt to Equity 0%
Total Debt to Equity 0%
Interest Coverage 0
Management Effectiveness
Return On Assets -6.6%
Ret/ On Assets - 3 Yr. Avg. 5.3%
Return On Total Capital -7.7%
Ret/ On T. Cap. - 3 Yr. Avg. 6%
Return On Equity -7.7%
Return On Equity - 3 Yr. Avg. 6%
Asset Turnover 0.9
Profitability Ratios
Gross Margin 70.4%
Gross Margin - 3 Yr. Avg. 67.9%
EBITDA Margin -7.4%
EBITDA Margin - 3 Yr. Avg. 3.6%
Operating Margin -25.9%
Oper. Margin - 3 Yr. Avg. -20.4%
Pre-Tax Margin -11.1%
Pre-Tax Margin - 3 Yr. Avg. -2.1%
Net Profit Margin -7.4%
Net Profit Margin - 3 Yr. Avg. 5.2%
Effective Tax Rate 33.3%
Eff/ Tax Rate - 3 Yr. Avg. 5.6%
Payout Ratio 0%

MSON stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the MSON stock intrinsic value calculation we used $27.269963 million for the last fiscal year's total revenue generated by Misonix. The default revenue input number comes from 0001 income statement of Misonix. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our MSON stock valuation model: a) initial revenue growth rate of 60% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for MSON is calculated based on our internal credit rating of Misonix, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Misonix.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of MSON stock the variable cost ratio is equal to 125.9%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for MSON stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Misonix.

Corporate tax rate of 27% is the nominal tax rate for Misonix. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the MSON stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for MSON are equal to 16.4%.

Life of production assets of 5.4 years is the average useful life of capital assets used in Misonix operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for MSON is equal to 21.6%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $28.139842 million for Misonix - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 9.405 million for Misonix is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Misonix at the current share price and the inputted number of shares is $0.1 billion.

RELATED COMPANIES Price Int.Val. Rating
SYK Stryker 168.72 100.38  sell
JNJ Johnson&Johnso 144.50 176.79  buy
IART Integra LifeSc 53.47 59.90  hold
BVX Bovie Medical 5.90 0.15  str.sell
CNMD CONMED 68.83 45.97  sell

COMPANY NEWS

▶ Misonix: Fiscal 1Q Earnings Snapshot   [Nov-08-18 07:45PM  Associated Press]
▶ Who Are The Major Shareholders In Misonix Inc (NASDAQ:MSON)?   [Jun-07-18 01:22PM  Simply Wall St.]
▶ Misonix: Fiscal 3Q Earnings Snapshot   [May-07-18 05:28PM  Associated Press]
▶ Misonix Reports Record Third Quarter Revenue   [04:05PM  GlobeNewswire]
▶ Misonix, Inc. to Host Earnings Call   [12:15PM  ACCESSWIRE]
▶ One Thing To Consider Before Buying Misonix Inc (NASDAQ:MSON)   [Mar-12-18 07:26AM  Simply Wall St.]
▶ Misonix reports 2Q loss   [Feb-06-18 06:17PM  Associated Press]
▶ Misonix, Inc. to Host Earnings Call   [12:00PM  ACCESSWIRE]
▶ Closing Bell Ringer, January 10, 2018   [Jan-10-18 03:59PM  CNBC Videos]
▶ Misonix to Ring Nasdaq Closing Bell on January 10   [Jan-09-18 11:00AM  GlobeNewswire]
▶ ETFs with exposure to Misonix, Inc. : December 26, 2017   [Dec-26-17 11:49AM  Capital Cube]
▶ ETFs with exposure to Misonix, Inc. : November 9, 2017   [Nov-09-17 12:56PM  Capital Cube]
▶ Misonix reports 1Q loss   [Nov-07-17 07:56PM  Associated Press]
▶ MISONIX INC to Host Earnings Call   [10:30AM  ACCESSWIRE]
▶ Misonix to Exhibit at NASS 2017   [Oct-12-17 12:00PM  GlobeNewswire]
▶ ETFs with exposure to Misonix, Inc. : October 2, 2017   [Oct-02-17 10:57AM  Capital Cube]
▶ ETFs with exposure to Misonix, Inc. : August 31, 2017   [Aug-31-17 07:28PM  Capital Cube]
▶ Misonix Appoints Joseph Dwyer as Chief Financial Officer   [Aug-23-17 04:05PM  GlobeNewswire]
▶ Misonix Reports Fiscal Year 2017 Financial Results   [Aug-22-17 04:05PM  GlobeNewswire]
▶ ETFs with exposure to Misonix, Inc. : July 12, 2017   [Jul-12-17 02:48PM  Capital Cube]
▶ ETFs with exposure to Misonix, Inc. : May 19, 2017   [May-19-17 02:01PM  Capital Cube]
▶ ETFs with exposure to Misonix, Inc. : May 8, 2017   [May-08-17 04:57PM  Capital Cube]
▶ Misonix reports 3Q loss   [May-02-17 06:02PM  Associated Press]
▶ ETFs with exposure to Misonix, Inc. : April 5, 2017   [Apr-05-17 05:07PM  Capital Cube]
▶ Misonix reports 2Q loss   [04:44PM  Associated Press]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.